1149336 ONTARIO INC.

Patent Owner

Stats

21 total patents issued
15 Total Apps Published
Nov 10, 2011 most recent publication

Details

21 Issued Patents
3 Issued in last 3 years
4 Published in last 3 years

344 Total Citation Count
Apr 14, 1995 Earliest Filing
1 Expired/Abandoned Patents

Technologies

A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 180.02

C07K PEPTIDES 40.03

A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 10.01

G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 10.00

		# of Patents	% of Class
A61K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
	Owner Portfolio	18	0.02
	US DEPT HEALTH & HUMAN SERVICES	944	1.22
	BRISTOL-MYERS SQUIBB COMPANY	917	1.18
	WYETH	891	1.15
	L'OREAL	836	1.08
	REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE	828	1.07
C07K	PEPTIDES
	Owner Portfolio	4	0.03
	GENENTECH, INC.	893	5.58
	US DEPT HEALTH & HUMAN SERVICES	385	2.41
	REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE	323	2.02
	HUMAN GENOME SCIENCES, INC.	286	1.79
	AMGEN INC.	203	1.27
A01N	PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF
	Owner Portfolio	1	0.01
	BASF AKTIENGESELLSCHAFT	403	2.80
	BAYER CROPSCIENCE AG	284	1.97
	BAYER AKTIENGESELLSCHAFT	257	1.78
	SUMITOMO CHEMICAL COMPANY, LIMITED	166	1.15
	REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE	158	1.10
G01N	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
	Owner Portfolio	1	0.00
	REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE	467	1.05
	GENERAL ELECTRIC COMPANY	460	1.03
	HITACHI, LTD.	456	1.02
	SIEMENS HEALTHCARE DIAGNOSTICS INC.	406	0.91
	HITACHI HIGH-TECHNOLOGIES CORPORATION	351	0.79

Top Patents (by citation)

6,803,357 Method of regulating glucose metabolism, and reagents related theretoJan 05, 01Oct 12, 04[A61K]46

5,834,428 Glucagon-like peptide-2 and its therapeutic useJun 28, 96Nov 10, 98[A61K]42

5,952,301 Compositions and methods for enhancing intestinal functionDec 10, 96Sep 14, 99[A61K]24

6,184,201 Intestinotrophic glucagon-like peptide-2 analogsApr 08, 97Feb 06, 01[A61K, C07K]23

6,051,557 Methods of enhancing functioning of the upper gastrointestinal tractApr 13, 98Apr 18, 00[A61K]22

5,789,379 Glucagon-like peptide-2 analogsJun 28, 96Aug 04, 98[A61K, C07K]22

5,846,937 Method of using exendin and GLP-1 to affect the central nervous systemMar 03, 97Dec 08, 98[A61K, C07K]21

6,890,898 Method of regulating glucose metabolism, and reagents related theretoJul 03, 02May 10, 05[A61K]14

5,990,077 Glucagon-like peptide-2 and its therapeutic useApr 14, 95Nov 23, 99[A61K]14

7,049,284 Glucagon-like peptide-2 and its therapeutic useNov 20, 02May 23, 06[A01N]10

Recent Publications

2011/0275,568 METHODS OF ENHANCING FUNCTIONING OF THE LARGE INTESTINEMay 06, 11Nov 10, 11[A61P, A61K]

2011/0223,108 GLUCAGON-LIKE PEPTIDE-2 AND ITS THERAPEUTIC USEDec 22, 10Sep 15, 11[A61P, A61K, C07K]

2011/0172,149 Method of Regulating Glucose Metabolism, and Reagents Related TheretoNov 09, 10Jul 14, 11[A61P, A61K]

2010/0119,453 METHODS OF ENHANCING FUNCTIONING OF THE LARGE INTESTINEOct 16, 09May 13, 10[A61P, A61K]

2009/0082,309 Method of Regulating Glucose Metabolism, and Reagents Related TheretoNov 26, 08Mar 26, 09[A61P, A61K]

2007/0129,304 Methods of enhancing functioning of the large intestineJan 18, 07Jun 07, 07[A61K]

2006/0105,954 Glucagon-like peptide-2 and its therapeutic useJan 05, 06May 18, 06[A61K]

2004/0198,642 Enhancement of GLP-2 activityApr 22, 04Oct 07, 04[A61K]

2004/0176,307 Method of regulating glucose metabolism, and reagents related theretoMar 04, 04Sep 09, 04[A61K]

2004/0132,025 Ampk-related serine/threonine kinase, designated snarkJul 02, 03Jul 08, 04[C12N, C07H, C12Q]

Top Innovators

Toronto, CA

Not Provided

Not Provided

Not Provided

San Diego, CA

Bolton, CA

Lovshin Julie Ann Louise

Toronto, CA

Bachovchin William W

Not Provided

Bachovchin William A

Melrose, MA

Drucker Daniel

Not Provided